Works matching AU Niu, Yanling
Results: 10
Mck1 defines a key S-phase checkpoint effector in response to various degrees of replication threats.
- Published in:
- PLoS Genetics, 2019, v. 15, n. 8, p. 1, doi. 10.1371/journal.pgen.1008136
- By:
- Publication type:
- Article
Molecular and clinical characteristics of IDH mutations in Chinese NSCLC patients and potential treatment strategies.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 22, p. 4122, doi. 10.1002/cam4.4764
- By:
- Publication type:
- Article
Role for Protein Kinase A in the Neurospora Circadian Clock by Regulating White Collar-Independent frequency Transcription through Phosphorylation of RCM-1.
- Published in:
- Molecular & Cellular Biology, 2015, v. 35, n. 12, p. 2088, doi. 10.1128/MCB.00709-14
- By:
- Publication type:
- Article
The Helicase Activity of Hyperthermophilic Archaeal MCM is Enhanced at High Temperatures by Lysine Methylation.
- Published in:
- Frontiers in Microbiology, 2015, v. 6, p. 1, doi. 10.3389/fmicb.2015.01247
- By:
- Publication type:
- Article
Plonmarlimab, a novel anti‐GM‐CSF blocking antibody, ameliorates disease progression in the pre‐clinical model of macrophage activation syndrome.
- Published in:
- Immunology, 2024, v. 173, n. 3, p. 552, doi. 10.1111/imm.13842
- By:
- Publication type:
- Article
Genomic and Transcriptional Profiling of Chinese Melanoma Patients Enhanced Potentially Druggable Targets: A Multicenter Study.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 283, doi. 10.3390/cancers15010283
- By:
- Publication type:
- Article
In Situ Fabrication of Silver Nanoparticle‐Decorated Polymeric Vesicles for Antibacterial Applications.
- Published in:
- ChemistryOpen, 2024, v. 13, n. 5, p. 1, doi. 10.1002/open.202300223
- By:
- Publication type:
- Article
Prior Therapy With Pegylated-Interferon Alfa-2b Improves the Efficacy of Adjuvant Pembrolizumab in Resectable Advanced Melanoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.675873
- By:
- Publication type:
- Article
Balancing acts of SRI and an auto-inhibitory domain specify Set2 function at transcribed chromatin.
- Published in:
- Nucleic Acids Research, 2015, v. 43, n. 10, p. 4881, doi. 10.1093/nar/gkv393
- By:
- Publication type:
- Article
Association of KMT2C/D loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer.
- Published in:
- Cancer Science, 2023, v. 114, n. 4, p. 1229, doi. 10.1111/cas.15716
- By:
- Publication type:
- Article